98 related articles for article (PubMed ID: 17208268)
21. Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity.
Vzorov AN; Gernert KM; Compans RW
Virology; 2005 Feb; 332(1):89-101. PubMed ID: 15661143
[TBL] [Abstract][Full Text] [Related]
22. Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.
Arthur LO; Bess JW; Chertova EN; Rossio JL; Esser MT; Benveniste RE; Henderson LE; Lifson JD
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S311-9. PubMed ID: 9814959
[TBL] [Abstract][Full Text] [Related]
23. Oligomeric structure of virion-associated and soluble forms of the simian immunodeficiency virus envelope protein in the prefusion activated conformation.
Center RJ; Schuck P; Leapman RD; Arthur LO; Earl PL; Moss B; Lebowitz J
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14877-82. PubMed ID: 11752436
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.
Kirschman J; Qi M; Ding L; Hammonds J; Dienger-Stambaugh K; Wang JJ; Lapierre LA; Goldenring JR; Spearman P
J Virol; 2018 Mar; 92(5):. PubMed ID: 29212940
[TBL] [Abstract][Full Text] [Related]
25. Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
Wang BZ; Liu W; Kang SM; Alam M; Huang C; Ye L; Sun Y; Li Y; Kothe DL; Pushko P; Dokland T; Haynes BF; Smith G; Hahn BH; Compans RW
J Virol; 2007 Oct; 81(20):10869-78. PubMed ID: 17670815
[TBL] [Abstract][Full Text] [Related]
26. Substantial envelope-specific CD8 T-cell immunity fails to control SIV disease.
Peut V; Kent SJ
Virology; 2009 Feb; 384(1):21-7. PubMed ID: 19091370
[TBL] [Abstract][Full Text] [Related]
27. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
[TBL] [Abstract][Full Text] [Related]
28. Visna/maedi virus Env protein expressed by a vaccinia virus recombinant induces cell-to-cell fusion in cells of different origins in the apparent absence of Env cleavage: role of glycosylation and of proteoglycans.
Sánchez AB; Rodríguez D; Garzón A; Amorena B; Esteban M; Rodríguez JR
Arch Virol; 2002 Dec; 147(12):2377-92. PubMed ID: 12491104
[TBL] [Abstract][Full Text] [Related]
29. Envelope glycoproteins are dispensable for insertion of host HLA-DR molecules within nascent human immunodeficiency virus type 1 particles.
Martin G; Beauséjour Y; Thibodeau J; Tremblay MJ
Virology; 2005 May; 335(2):286-90. PubMed ID: 15840527
[TBL] [Abstract][Full Text] [Related]
30. Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells.
Pfeiffer T; Pisch T; Devitt G; Holtkotte D; Bosch V
FEBS Lett; 2006 Jun; 580(15):3775-8. PubMed ID: 16777098
[TBL] [Abstract][Full Text] [Related]
31. Optimized protocol for the large scale production of HIV pseudovirions by transient transfection of HEK293T cells with linear fully deacylated polyethylenimine.
Devitt G; Thomas M; Klibanov AM; Pfeiffer T; Bosch V
J Virol Methods; 2007 Dec; 146(1-2):298-304. PubMed ID: 17719656
[TBL] [Abstract][Full Text] [Related]
32. Selection and characterization of a replication-competent human immunodeficiency virus type 1 variant encoding C-terminally truncated env.
Holtkotte D; Pfeiffer T; Pisch T; Bosch V
AIDS Res Hum Retroviruses; 2006 Jan; 22(1):57-65. PubMed ID: 16438647
[TBL] [Abstract][Full Text] [Related]
33. Advances in methods for the production, purification, and characterization of HIV-1 Gag-Env pseudovirion vaccines.
Hammonds J; Chen X; Zhang X; Lee F; Spearman P
Vaccine; 2007 Nov; 25(47):8036-48. PubMed ID: 17936444
[TBL] [Abstract][Full Text] [Related]
34. Second-site revertants of a simian immunodeficiency virus gp41 mutant defective in envelope glycoprotein incorporation.
Celma CC; Manrique JM; Hunter E; Affranchino JL; González SA
AIDS Res Hum Retroviruses; 2004 Jul; 20(7):733-41. PubMed ID: 15307919
[TBL] [Abstract][Full Text] [Related]
35. HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles.
Legoff J; Bouhlal H; Lecerf M; Klein C; Hocini H; Si-Mohamed A; Muggeridge M; Bélec L
Virol J; 2007 Jan; 4():2. PubMed ID: 17207276
[TBL] [Abstract][Full Text] [Related]
36. Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles.
Skountzou I; Quan FS; Gangadhara S; Ye L; Vzorov A; Selvaraj P; Jacob J; Compans RW; Kang SM
J Virol; 2007 Feb; 81(3):1083-94. PubMed ID: 17108046
[TBL] [Abstract][Full Text] [Related]
37. Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.
Bachrach E; Dreja H; Lin YL; Mettling C; Pinet V; Corbeau P; Piechaczyk M
Virology; 2005 Feb; 332(1):418-29. PubMed ID: 15661172
[TBL] [Abstract][Full Text] [Related]
38. Understanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency viruses.
Affranchino JL; González SA
Viruses; 2014 Jan; 6(1):264-83. PubMed ID: 24441862
[TBL] [Abstract][Full Text] [Related]
39. Basolateral sorting of the HIV type 2 and SIV envelope glycoproteins in polarized epithelial cells: role of the cytoplasmic domain.
Ball JM; Mulligan MJ; Compans RW
AIDS Res Hum Retroviruses; 1997 May; 13(8):665-75. PubMed ID: 9168235
[TBL] [Abstract][Full Text] [Related]
40. Intracellular interaction of simian immunodeficiency virus Gag and Env proteins.
Vincent MJ; Melsen LR; Martin AS; Compans RW
J Virol; 1999 Oct; 73(10):8138-44. PubMed ID: 10482563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
